Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × epratuzumab × Clear all

NCT00301821 2019-10-09

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Phase 2 Completed

107 enrolled 8 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00042913 2013-12-19

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Lymphoma, Large B-Cell, Diffuse